SCHEMBL14324044

SCHEMBL14324044

COc1cccn(Cc2ccccc2)c1=S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 4/20 0.58
▸ HDAC6 Q9UBN7 4/20 0.58
▸ IL1RN P18510 1/20 0.49
▸ ERAP2 Q6P179 1/20 0.49
▸ ERAP1 Q9NZ08 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47
▸ KMT2A Q03164 2/20 0.45
▸ GFER P55789 1/20 0.45
▸ CXCR2 P25025 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ DBH P09172 2/20 0.44
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ BRD2 P25440 1/20 0.42
▸ BRD3 Q15059 1/20 0.42
▸ BRDT Q58F21 1/20 0.42
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16199217 0.87 HDAC8 (0.58) HDAC8HDAC6IL1RNERAP2ERAP1
SCHEMBL14323729 0.81 HDAC8 (0.65) HDAC8HDAC6IL1RNERAP2ERAP1
SCHEMBL14324139 0.80 LMNA (0.57) TP53TDP1KMT2AALDH1A1LMNA
SCHEMBL28179434 0.78 TP53 (0.49) HDAC8HDAC6TP53TDP1KMT2A
SCHEMBL14322583 0.75 HDAC8 (0.67) HDAC8HDAC6L3MBTL1
SCHEMBL14323420 0.74 HDAC8 (1.00) HDAC8HDAC6ALDH1A1DBHKDM4E
SCHEMBL216021 0.73 CNR2 (0.54) IL1RNERAP2ERAP1TP53
SCHEMBL28375979 0.71 KCNA3 (0.53) TP53TDP1KMT2AALDH1A1LMNA
SCHEMBL6775018 0.71 HTR6 (0.61) TP53TDP1KMT2AMEN1KDM4E
SCHEMBL28178688 0.71 PDE4A (0.50) KMT2AALDH1A1LMNAMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871728-B2 Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof GEORGIA TECH RESEARCH CORPORATION (US) 2014-10-28 — — US disclosed
US-20120329741-A1 NON-PEPTIDE MACROCYCLIC HISTONE DEACETYLASE (HDAC) INHIBITORS AND METHODS OF MAKING AND USING THEREOF GEORGIA TECH RESEARCH CORPORATION 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329741-A1 NON-PEPTIDE MACROCYCLIC HISTONE DEACETYLASE (HDAC) INHIBITORS AND METHODS OF MAKING AND USING THEREOF HDAC5, HDAC3, HDAC1 HDAC8 9/4885HDAC6 11/4885IL1RN 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback